| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 1,902.10 | 1,758.49 | 1,677.24 | 1,632.88 |
| Other Net | 5.51 | 1.29 | -0.33 | 0.60 |
| Diluted Weighted Average Shares | 8.34 | 8.32 | 8.31 | 8.29 |
| Gain( Loss)on Saleof Assets | -2.15 | -0.22 | 0.81 | -0.60 |
| Depreciation/ Amortization | 141.58 | 143.34 | 150.19 | 108.11 |
| Operating Income | 559.30 | 468.15 | 339.64 | 454.53 |
| Net Income | 487.14 | 357.74 | 238.85 | 344.83 |
| Income Availableto Com Excl Extra Ord | 487.14 | 357.74 | 238.85 | 344.83 |
| Other Operating Expenses Total | 31.35 | 41.93 | 37.08 | 37.81 |
| Net Income Before Taxes | 624.80 | 505.45 | 343.83 | 474.98 |
| Minority Interest | -5.11 | -4.56 | -2.23 | -5.46 |
| Interest Exp( Inc) Net- Operating Total | 0.35 | 0.26 | - | - |
| Net Income After Taxes | 492.25 | 362.29 | 241.08 | 350.29 |
| Income Availableto Com Incl Extra Ord | 487.14 | 357.74 | 238.85 | 344.83 |
| Costof Revenue Total | 508.62 | 477.59 | 473.06 | 524.37 |
| Gross Profit | 1,952.77 | 1,749.05 | 1,543.82 | 1,563.04 |
| Interest Inc( Exp) Net- Non- Op Total | 62.15 | 36.23 | 3.71 | 20.45 |
| Diluted Net Income | 487.14 | 357.74 | 238.85 | 344.83 |
| DPS- Common Stock Primary Issue | 24.00 | 24.00 | 12.00 | 12.00 |
| Provisionfor Income Taxes | 132.55 | 143.16 | 102.75 | 124.69 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 487.14 | 357.74 | 238.85 | 344.83 |
| Total Revenue | 2,461.40 | 2,226.64 | 2,016.88 | 2,087.41 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 2,461.40 | 2,226.64 | 2,016.88 | 2,087.41 |
| Selling/ General/ Admin Expenses Total | 1,220.20 | 1,095.38 | 1,016.91 | 962.59 |
| Diluted Normalized EPS | 58.60 | 43.00 | 28.67 | 41.63 |
| Diluted EPS Excluding Extra Ord Items | 58.40 | 42.98 | 28.74 | 41.57 |
| Dilution Adjustment | - | - | - | 0.00 |
Dr. Lal PathLabs Dividend Dr. Lal PathLabs Bonus Dr. Lal PathLabs News Dr. Lal PathLabs AGM Dr. Lal PathLabs Rights Dr. Lal PathLabs Splits Dr. Lal PathLabs Board Meetings Dr. Lal PathLabs Key Metrics Dr. Lal PathLabs Shareholdings Dr. Lal PathLabs Balance Sheet Dr. Lal PathLabs Cashflow Dr. Lal PathLabs Q1 Results Dr. Lal PathLabs Q2 Results Dr. Lal PathLabs Q3 Results Dr. Lal PathLabs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks